6 days ago Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks Equity Research June 04, 2020. AGEN NTLA. Trades from
Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Intellia Therapeutics (NTLA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Intellia Therapeutics Inc. company facts, information and stock details by MarketWatch. View ntla business summary and other industry information. Stock screener for investors and traders, financial visualizations. Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks. Jun-04-20 01:55AM : Edited Transcript of NTLA earnings conference call or presentation 7-May-20 12:00pm GMT. Thomson Reuters StreetEvents-7.57%. Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2% Zacks Equity Research - Zacks Investment Research - Thu Jun 4, 11:37PM CDT Zacks Equity Research - ZACKS - Thu Jun 4, 11:37PM CDT Intellia Therapeutics (NTLA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes. Implied Volatility Surging for Intellia (NTLA) Stock Options Zacks Equity Research - Zacks Investment Research - Fri Feb 7, 7:54AM CST Zacks Equity Research - ZACKS - Fri Feb 7, 7:54AM CST Investors need to pay close attention to Intellia (NTLA) stock based on the movements in the options market lately. Zacks Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2% Intellia Therapeutics (NTLA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes. View Intellia Therapeutics Inc NTLA investment & stock information. Get the latest Intellia Therapeutics Inc NTLA detailed stock quotes, stock data, Real-Time Inc. (NTLA)? Use the Zacks Rank and Style Scores to find out is NTLA is right for your portfolio. View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks
NTLA: Intellia Therapeutics Inc - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Intellia Therapeutics Inc from Zacks Investment Research Implied Volatility Surging for Intellia (NTLA) Stock Options by Zacks Equity Research Published on February 07,2020 Investors need to pay close attention to Intellia (NTLA) stock based on the NTLA: Intellia Therapeutics Inc - Full Company Report. Get the latest Full Company Report for Intellia Therapeutics Inc from Zacks Investment Research NTLA: Intellia Therapeutics Inc broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Intellia Therapeutics Inc (NASDAQ:NTLA) released its quarterly earnings data on Thursday, May, 7th. The company reported ($0.63) EPS for the quarter, missing the Zacks' consensus estimate of ($0.39) by $0.24. Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Intellia Therapeutics (NTLA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Stock screener for investors and traders, financial visualizations. Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks. Jun-04-20 01:55AM : Edited Transcript of NTLA earnings conference call or presentation 7-May-20 12:00pm GMT. Thomson Reuters StreetEvents-7.57%.
Market Cap is a widely used stock evaluation measure. Find the latest Market Cap for Intellia Therapeutics Inc (NTLA)
NTLA: Intellia Therapeutics Inc broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Intellia Therapeutics Inc (NASDAQ:NTLA) released its quarterly earnings data on Thursday, May, 7th. The company reported ($0.63) EPS for the quarter, missing the Zacks' consensus estimate of ($0.39) by $0.24. Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Intellia Therapeutics (NTLA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
20 Feb 2020 Intellia (NTLA) to Report Q4 Earnings: What's in Store? Zacks Equity Research February 20, 2020. NVS SAGE CLVS NTLA.
6 days ago Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks Equity Research June 04, 2020. AGEN NTLA. Trades from 30 Apr 2020 What You Should Know. Zacks Equity Research April 30, 2020. NTLA. Trades from $1. 20 Feb 2020 Intellia (NTLA) to Report Q4 Earnings: What's in Store? Zacks Equity Research February 20, 2020. NVS SAGE CLVS NTLA. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and Zacks · Globalstar (GSAT) Looks Good: Stock Adds 8.9% in Session. Zacks. 6 days ago AGEN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. These Stocks Are Poised to NTLA Intellia Therapeutics, Inc. daily Stock Chart Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks. Jun-04-20 01:55AM. Edited Transcript Podcast by Zacks Investment Research. (0:45) - Finding Zacks #1 Rank Value Stocks (7:00) - Tracey's Top Stock Picks (21:25) - Episode Roundup: AMKR,
20 Feb 2020 Intellia (NTLA) to Report Q4 Earnings: What's in Store? Zacks Equity Research February 20, 2020. NVS SAGE CLVS NTLA.
NTLA Intellia Therapeutics, Inc. daily Stock Chart Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%. Zacks. Jun-04-20 01:55AM. Edited Transcript Podcast by Zacks Investment Research. (0:45) - Finding Zacks #1 Rank Value Stocks (7:00) - Tracey's Top Stock Picks (21:25) - Episode Roundup: AMKR,